[1]梁汇珉,李赵伟,李铮,等.脑源性神经营养因子对糖尿病大鼠视网膜Müller细胞的保护作用[J].眼科新进展,2017,37(12):1110-1113.[doi:10.13389/j.cnki.rao.2017.0280]
　LIANG Hui-Min,LI Zhao-Wei,LI Zheng,et al.Effect of brain-derived neurotrophic factor on retinal Müller cells in diabetic rats[J].Recent Advances in Ophthalmology,2017,37(12):1110-1113.[doi:10.13389/j.cnki.rao.2017.0280]
点击复制

脑源性神经营养因子对糖尿病大鼠视网膜Müller细胞的保护作用/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年12期
页码:
1110-1113
栏目:
实验研究
出版日期:
2017-12-05

文章信息/Info

Title:
Effect of brain-derived neurotrophic factor on retinal Müller cells in diabetic rats
作者:
梁汇珉; 李赵伟; 李铮; 左中夫; 刘学政
121001　辽宁省锦州市，锦州医科大学基础医学院解剖学教研室
Author(s):
LIANG Hui-Min; LI Zhao-Wei; LI Zheng; ZUO Zhong-Fu; LIU Xue-Zheng
Department of Anatomy，School of Basic Medical Sciences，Jinzhou Medical University，Jinzhou 121001，Liaoning Province，China
关键词:
脑源性神经营养因子; 糖尿病视网膜病变; Müller细胞; L-谷氨酸/L-天冬氨酸转运体
Keywords:
brain-derived neurotrophic factor; diabetic retinopathy; Müller cells; L-glutamate/L-aspartate transporter
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2017.0280
文献标志码:
A
摘要:
目的　探讨脑源性神经营养因子对糖尿病视网膜Müller细胞的保护作用。方法　健康雄性SD大鼠54只，腹腔注射链脲佐菌素建立糖尿病模型。随机分为对照组、糖尿病组、脑源性神经营养因子（brain derived neurotrophic factor，BDNF）组。含0.1 g·L-1 BSA的PBS平衡盐溶液制备BDNF注射液。BDNF组大鼠于糖尿病模型建成4周后开始注射BDNF注射液，对照组和糖尿病组注射等剂量的PBS平衡盐溶液。8周后，利用免疫荧光及Western blot检测胶质细胞谷氨酸转运体（L-glutamate/L-aspartate transporter，GLAST）、谷氨酰胺合成酶（glutamine synthetase，GS）及神经元标记物SYN（synaptophysin）的表达量，谷氨酸含量测定试剂盒检测视网膜中谷氨酸的含量。结果　与对照组相比，糖尿病组GLAST、GS、SYN表达显著下降，且视网膜谷氨酸含量均明显升高（均为P<0.01），而BDNF组差异均无统计学意义（均为P>0.05）；与糖尿病组相比，BDNF组GLAST、GS、SYN表达均升高（均为P<0.01），谷氨酸含量均显著减少（均为P<0.01）。结论　糖尿病视网膜病变早期给予外源性BDNF可以提高Müller细胞中GLAST、SYN及GS表达活性，改善Müller细胞功能，并且能使视网膜神经节细胞免受损害，提示BDNF对糖尿病视网膜病变条件下视网膜中的Müller细胞具有保护作用。
Abstract:
Objective　To investigate the protective effect of brain derived neurotrophic factor （BDNF） on Müller cells in the retina of diabetic rats.Methods　A total of 54 healthy male SD rats were recruited and randomly divided into control group，diabetic group and BDNF group.Then a diabetic model was established by intraperitoneal injection of streptozotocin in rats of diabetic and BDNF groups.Preparation of BDNF injection was performed using PBS balanced salt solution containing 0.1 g·L-1 BSA.The BDNF group was given BDNF injection，while the control and diabetic group were injected with equal dose of PBS balanced salt solution 4 weeks after successful modeling.And after 8 weeks，the expression of L-glutamate/L-aspartate transporter （GLAST），glutamine synthetase （GS） and synaptophysin （SYN） were detected by immunofluorescence technique and Western blot，and the content of glutamic acid in retina was determined by glutamic acid determination kit.Results　Compared with the control group，the expression of GLAST，GS and SYN were significantly decreased in diabetic group，and the content of glutamic acid was increased significantly （all P<0.01）.Compared with the diabetic group，the expression of GLAST，GS and SYN were increased in BDNF group，and the glutamate level was decreased significantly （all P<0.01）.Conclusion　In the early stage of diabetic retinopathy，administration of exogenous BDNF can unregulated the expression of GLAST，SYN and GS and improve the function of Müller cells to protect RGC against damage，suggesting that BDNF has neuroprotective effects on Müller cells in retina of rats with diabetic retinopathy.

参考文献/References:

［1］　TING DS，CHEUNG GC，WONG TY.Diabetic retinopathy：global prevalence，major risk factors，screening practices and public health challenges：a review［J］.Clin Exp Ophthalmol，2016，44（4）：260-277.
［2］　VILLARROEL M，CIUDIN A，HERNANDEZ C，SIMO R.Neurodegeneration：An early event of diabetic retinopathy［J］.World J Diabetes，2010，1（2）：57-64.
［3］　WANG L，DENG QQ，WU XH，YU J，YANG XL，ZHONG YM.Upregulation of glutamate-aspartate transporter by glial cell line-derived neurotrophic factor ameliorates cell apoptosis in neural retina in streptozotocin-induced diabetic rats［J］.CNS Neurosci Ther，2013，19（12）：945-953.
［4］　BERK BA，VOGLER S，PANNICKE T，KUHRT H，GARCIA TB，WIEDEMANN P，et al.Brain-derived neurotrophic factor inhibits osmotic swelling of rat retinal glial （Müller） and bipolar cells by activation of basic fibroblast growth factor signaling［J］.Neuroscience，2015，295：175-186.
［5］　SAITO T，ABE T，WAKUSAWA R，SATO H，ASAI H，TOKITA-ISHIKAWA Y，et al.TrkB-T1 receptors on Müller cells play critical role in brain-derived neurotrophic factor-mediated photoreceptor protection against phototoxicity［J］.Curr Eye Res，2009，34（7）：580-588.
［6］　HARADA C，GUO X，NAMEKATA K，KIMURA A，NAKAMURA K，TANAKA K，et al.Glia- and neuron-specific functions of TrkB signalling during retinal degeneration and regeneration［J］.Nat Commun，2011，2：189.
［7］　REICHENBACH A，BRINGMANN A.New functions of Müller cells［J］.Glia，2013，61（5）：651-678.
［8］　SIM R，HERNNDEZ C.Neurodegeneration in the diabetic eye：new insights and therapeutic perspectives［J］.Trends Endocrinol Metab，2014，25（1）：23-33.
［9］　BRUNET A，DATTA SR，GREENBERG ME.Transcription-dependent and-independent control of neuronal survival by the PI3K-Akt signaling pathway［J］.Curr Opin Neurobiol，2001，11（3）：297-305.
［10］　ARTHUR JS，FONG AL，DWYER JM，DAVARE M，REESE E，OBRIETAN K，et al.Mitogen-and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins［J］.J Neurosci，2004，24（18）：4324-4332.
［11］　LEHRE KP，DAVANGER S，DANBOLT NC.Localization of the glutamate transporter protein GLAST in rat retina［J］.Brain Res，1997，744（1）：129-137.
［12］　LLHA J，CENTENARO LA，BROETTO CUNHA N，DE SOUZA DF，JAEGER M，DO NASCIMENTO PS，et al.The beneficial effects of treadmill step training on activity-dependent synaptic and cellular plasticity markers after complete spinal cord injury［J］.Neurochem Res，2011，36（6）：1046-1055.
［13］　OLA MS，MAWAZ MI，EI-ASRAR AA，ABOUAMMOH M，ALHOMIDA AS.Reduced levels of brain derived neurotrophic factor （BDNF） in the serum of diabetic retinopathy patients and in the retina of diabetic rats［J］.Cell Mol Neurobiol，2013，33（3）：359-367.

相似文献/References:

[1]殷晓贝 陈蕊 李根林.不同剂量脑源性神经营养因子作用下视网膜色素变性组织中 bcl-2蛋白的动态表达特征[J].眼科新进展,2012,32(5):000.
[2]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[3]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[4]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[5]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[6]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[7]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[8]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[9]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[10]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81571383）
更新日期/Last Update: 2017-12-08